文献速递细菌感染、耐药与抗菌药物医院感染防控

血浆微生物游离DNA定量测序:心脏植入式电子装置葡萄球菌感染诊断的潜在生物标志物

Quantitative Microbial Cell-Free DNA Sequencing From Plasma: A Potential Biomarker for the Diagnosis of Staphylococcal Infection of Cardiac Implantable Electronic Devices.
PubMed 文献 · Clin Infect Dis · 2025-01-01

本研究纳入16例葡萄球菌菌血症且被分类为确诊或可能心脏植入式电子装置感染性心内膜炎(CIED-IE)的患者,对 consent 时、拔除前及拔除后96小时内的血浆标本进行宏基因组测序并定量葡萄球菌游离DNA(mcfDNA)。确诊CIED-IE患者中mcfDNA持续存在中位11天,拔除后早期浓度显著升高而后快速下降;可能CIED-IE患者中mcfDNA在抗生素治疗6天后检测不到且拔除后仍检测不到,两组模式差异显著(P=0.001)。作者认为若被证实,该模式可作为生物标志物辅助诊断或排除金黄色葡萄球菌CIED-IE。

要点

  • 确诊CIED-IE患者中,11例有10例mcfDNA在抗生素治疗期间持续存在,中位11天(IQR 7.5-15天)。
  • 5例可能CIED-IE患者中,mcfDNA在抗生素治疗6天(IQR 5.5-7.5天)后检测不到,拔除后仍检测不到。
  • 两组mcfDNA模式差异显著(P=0.001),提示两个不同患者群体。

核心结论

  • 若被证实,这些mcfDNA模式可作为生物标志物,结合临床特征提高诊断或排除金黄色葡萄球菌CIED-IE的精确性。
  • 在CIED拔除前后策略性定时进行mcfDNA检测可能有助于规划治疗。

研究设计与样本

  • 研究纳入16例葡萄球菌菌血症且被分类为确诊或可能CIED-IE并建议移除装置的患者。
  • 入组条件为7天内有阳性血培养且无并发深部感染。
  • 在知情同意时、拔除前及拔除后96小时内获取血浆标本,进行宏基因组测序并定量葡萄球菌mcfDNA。

主要发现

  • 11例确诊CIED-IE患者中10例mcfDNA在抗生素治疗期间持续存在,中位持续时间11天(IQR 7.5-15天)。
  • 这些病例中,拔除导线后早期获取的血浆mcfDNA浓度显著升高,此后快速下降。
  • 5例可能CIED-IE患者中,mcfDNA在抗生素治疗6天(IQR 5.5-7.5天)后检测不到,且在CIED拔除后仍检测不到。
  • 两组mcfDNA模式差异显著(P=0.001),提示两个不同患者群体:一个为确诊CIED-IE,一个无导线感染。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Staphylococcus aureus bacteremia in patients with cardiac implantable electronic devices (CIEDs) is often associated with infective endocarditis (CIED-IE). The CIED-IE diagnosis is syndromic. Diagnostic uncertainty is common. Frequently, these patients are classified as having possible CIED-IE, resulting in guideline-noncompliant treatment and heterogeneous outcomes. Improved outcomes require accurate diagnoses. In these patients, we evaluated whether metagenomic sequencing of microbial cell-free DNA (mcfDNA) in serial plasma specimens could improve diagnostic precision. METHODS: We studied 16 patients with staphylococcal bacteremia who were classified with definite or possible CIED-IE and recommended for device removal, if there was a positive blood culture within 7 days and no concurrent deep infection. Plasma specimens obtained at consent, before extraction, and during 96 hours after extraction underwent metagenomic sequencing and quantification of staphylococcal mcfDNA. RESULTS: In 10 of 11 patients with definite CIED-IE, mcfDNA persisted during antibiotic therapy for prolonged durations (median, 11 days [interquartile range {IQR}, 7.5-15 days]). In these cases, mcfDNA concentration in plasma obtained early after lead extraction increased significantly and thereafter decreased rapidly. In 5 cases of possible CIED-IE, mcfDNA was undetectable after 6 days (IQR, 5.5-7.5 days) of antibiotic therapy and remained undetectable after CIED extraction. These mcfDNA patterns differ significantly (P = .001), suggesting 2 distinct patient populations: 1 with definite CIED-IE and 1 without lead infection. CONCLUSIONS: If confirmed, these mcfDNA patterns can serve as biomarkers, together with clinical features, to improve precision in diagnosing or rejecting S. aureus CIED-IE. Strategically timed mcfDNA testing before and after CIED extraction may aid in planning therapy.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Karchmer AW, Kaufman NJ, Park SY, et al. Quantitative Microbial Cell-Free DNA Sequencing From Plasma: A Potential Biomarker for the Diagnosis of Staphylococcal Infection of Cardiac Implantable Electronic Devices. Clin Infect Dis. 2025. PMID: 40066816. doi:10.1093/cid/ciaf113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。